Lille ALS center was created by Dr Veronique Brunaud Danel. It is devoted to the diagnosis and care of ALS and other motorneuron diseases patients. Our fields of work are randomized clinical trials, biomarkers and ethics.
| Contact information | |
|---|---|
| Address | Hôpital Roger Salengro, CHU |
| Contact | Prof. D. Devos |
| Phone | + 33 320446752 |
| david.devos@chru-lille.fr | |
| Website | Visit the website |
Publications
- Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review. Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Defebvre L. Rev Neurol (Paris). 2017 May;173(5):300-307.
- Clinical features of amyotrophic lateral sclerosis and their prognostic value. Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V. Rev Neurol (Paris). 2017 May;173(5):263-272.
- Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study. Blasco H, Garcon G, Patin F, Veyrat-Durebex C, Boyer J, Devos D, Vourc'h P, Andres CR, Corcia P. Can J Neurol Sci. 2017 Jan;44(1):90-95.
- RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease. Nkiliza A, Mutez E, Simonin C, Leprêtre F, Duflot A, Figeac M, Villenet C, Semaille P, Comptdaer T, Genet A, Sablonnière B, Devos D, Defebvre L, Destée A, Chartier-Harlin MC. Neurobiol Dis. 2016 Dec;96:312-322.
- New insights into the photoswitching mechanisms of normal dithienylethenes. Hamdi I, Buntinx G, Perrier A, Devos O, Jaïdane N, Delbaere S, Tiwari AK, Dubois J, Takeshita M, Wada Y, Aloïse S. Phys Chem Chem Phys. 2016 Oct 12;18(40):28091-28100.
Restricted information
| Serving population | |
|---|---|
| Serving population | Unknown |
| Patient resources | |
|---|---|
| Population based register | Yes |
| Clinic based register | Yes |
| Geographically matched controls | No |
Banks
| Type | ALS Patients | Controls | Other |
|---|---|---|---|
| Biobank | |||
| Radiological bank |
| Research activities | |
|---|---|
| Clinical management research | Yes |
| Neuro epidemiology | No |
| Neuro physiology | Yes |
| Neuro imaging | Yes |
| Neuro psychology | Yes |
| Neuro pathology | No |
| Genomics | Yes |
| Transcriptomics | No |
| Metabolomics | Yes |
Clinical Trials - Industry sponsored
There are no clinical trials for this centre
Clinical Trials - Investigator initiated
| Name | Type | Patients |
|---|---|---|
| SAFEFAIRSLA | Efficacy and Safety of the Iron Chelator Deferiprone in Amyotrophic lateral sclerosis | |
| FAIR-ALS- II | Conservative Iron Chelation by Deferiprone as a Disease-modifying Strategy for Amyotrophic Lateral Sclerosis using a Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial (recruitment will start in 2018) | 210 |